| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 8.20e-08 | 6 | 33 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 8.20e-08 | 6 | 33 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.85e-06 | 15 | 33 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 7.94e-06 | 3 | 33 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 2.64e-05 | 5 | 33 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.90e-05 | 40 | 33 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.36e-04 | 73 | 33 | 3 | GO:0044183 | |
| GeneOntologyMolecularFunction | virus receptor activity | 3.70e-04 | 85 | 33 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 3.83e-04 | 86 | 33 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 3.99e-04 | 18 | 33 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | death receptor activity | 5.45e-04 | 21 | 33 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.32e-04 | 441 | 33 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.17e-03 | 126 | 33 | 3 | GO:0051082 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.61e-03 | 36 | 33 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 1.61e-03 | 36 | 33 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 1.89e-03 | 39 | 33 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 2.43e-03 | 163 | 33 | 3 | GO:0031072 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.15e-03 | 614 | 33 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 3.94e-03 | 938 | 33 | 6 | GO:0016772 | |
| GeneOntologyBiologicalProcess | protein refolding | 1.21e-05 | 30 | 31 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 1.95e-05 | 35 | 31 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 3.15e-05 | 41 | 31 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 3.27e-05 | 6 | 31 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 4.47e-05 | 46 | 31 | 3 | GO:0006458 | |
| GeneOntologyBiologicalProcess | heat acclimation | 4.57e-05 | 7 | 31 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.57e-05 | 7 | 31 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 6.09e-05 | 8 | 31 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 6.09e-05 | 8 | 31 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 7.45e-05 | 151 | 31 | 4 | GO:0007041 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.19e-04 | 11 | 31 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 1.43e-04 | 12 | 31 | 2 | GO:0090084 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 1.70e-04 | 187 | 31 | 4 | GO:0007034 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor-mediated signaling pathway | 1.97e-04 | 14 | 31 | 2 | GO:1903265 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 2.34e-04 | 80 | 31 | 3 | GO:0061077 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 2.42e-04 | 81 | 31 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.59e-04 | 16 | 31 | 2 | GO:0070424 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.79e-04 | 85 | 31 | 3 | GO:0032436 | |
| GeneOntologyBiologicalProcess | regulation of microtubule nucleation | 3.68e-04 | 19 | 31 | 2 | GO:0010968 | |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.08e-04 | 20 | 31 | 2 | GO:0070431 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 4.51e-04 | 21 | 31 | 2 | GO:0090083 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle assembly | 5.91e-04 | 24 | 31 | 2 | GO:1901673 | |
| GeneOntologyBiologicalProcess | positive regulation of ubiquitin-dependent protein catabolic process | 6.60e-04 | 114 | 31 | 3 | GO:2000060 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | 6.76e-04 | 478 | 31 | 5 | GO:0006979 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 7.49e-04 | 489 | 31 | 5 | GO:0043254 | |
| GeneOntologyBiologicalProcess | response to heat | 7.85e-04 | 121 | 31 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal protein catabolic process | 8.23e-04 | 123 | 31 | 3 | GO:1901800 | |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 9.26e-04 | 30 | 31 | 2 | GO:0035872 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 9.45e-04 | 129 | 31 | 3 | GO:0039531 | |
| GeneOntologyBiologicalProcess | cellular response to oxidative stress | 9.51e-04 | 295 | 31 | 4 | GO:0034599 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 1.12e-03 | 33 | 31 | 2 | GO:0070841 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.17e-03 | 139 | 31 | 3 | GO:0032434 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 1.19e-03 | 34 | 31 | 2 | GO:0090169 | |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis involved in protein catabolic process | 1.40e-03 | 148 | 31 | 3 | GO:1903052 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 1.41e-03 | 37 | 31 | 2 | GO:0031116 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 1.41e-03 | 37 | 31 | 2 | GO:0045648 | |
| GeneOntologyBiologicalProcess | viral life cycle | 1.61e-03 | 340 | 31 | 4 | GO:0019058 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1.65e-03 | 40 | 31 | 2 | GO:2001240 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction in absence of ligand | 1.65e-03 | 40 | 31 | 2 | GO:1901099 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 1.80e-03 | 351 | 31 | 4 | GO:0044403 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 1.81e-03 | 42 | 31 | 2 | GO:0031112 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.81e-03 | 42 | 31 | 2 | GO:0001916 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 1.90e-03 | 43 | 31 | 2 | GO:0071276 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 1.99e-03 | 44 | 31 | 2 | GO:0060236 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 2.05e-03 | 169 | 31 | 3 | GO:0046718 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 2.30e-03 | 176 | 31 | 3 | GO:0044409 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 2.34e-03 | 377 | 31 | 4 | GO:0062197 | |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 2.36e-03 | 48 | 31 | 2 | GO:0090224 | |
| GeneOntologyBiologicalProcess | protein targeting to vacuole | 2.46e-03 | 49 | 31 | 2 | GO:0006623 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 2.56e-03 | 50 | 31 | 2 | GO:1905710 | |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis | 2.64e-03 | 390 | 31 | 4 | GO:0045862 | |
| GeneOntologyBiologicalProcess | regulation of ubiquitin-dependent protein catabolic process | 2.65e-03 | 185 | 31 | 3 | GO:2000058 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 2.78e-03 | 188 | 31 | 3 | GO:0002753 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 2.87e-03 | 53 | 31 | 2 | GO:0001914 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 2.98e-03 | 54 | 31 | 2 | GO:2001239 | |
| GeneOntologyBiologicalProcess | regulation of pattern recognition receptor signaling pathway | 2.99e-03 | 193 | 31 | 3 | GO:0062207 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 3.31e-03 | 57 | 31 | 2 | GO:0007020 | |
| Domain | HSP70 | 2.52e-06 | 16 | 32 | 3 | PF00012 | |
| Domain | HSP70_2 | 3.06e-06 | 17 | 32 | 3 | PS00329 | |
| Domain | HSP70_3 | 3.06e-06 | 17 | 32 | 3 | PS01036 | |
| Domain | HSP70_1 | 3.06e-06 | 17 | 32 | 3 | PS00297 | |
| Domain | Hsp_70_fam | 3.66e-06 | 18 | 32 | 3 | IPR013126 | |
| Domain | TIL | 1.86e-04 | 12 | 32 | 2 | PF01826 | |
| Domain | - | 1.86e-04 | 12 | 32 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.86e-04 | 12 | 32 | 2 | IPR029047 | |
| Domain | C8 | 1.86e-04 | 12 | 32 | 2 | PF08742 | |
| Domain | - | 2.19e-04 | 13 | 32 | 2 | 1.20.1270.10 | |
| Domain | Unchr_dom_Cys-rich | 2.19e-04 | 13 | 32 | 2 | IPR014853 | |
| Domain | Heat_shock_70_CS | 2.19e-04 | 13 | 32 | 2 | IPR018181 | |
| Domain | HSP70_C | 2.19e-04 | 13 | 32 | 2 | IPR029048 | |
| Domain | C8 | 2.19e-04 | 13 | 32 | 2 | SM00832 | |
| Domain | TIL_dom | 2.55e-04 | 14 | 32 | 2 | IPR002919 | |
| Domain | VWFD | 3.36e-04 | 16 | 32 | 2 | PS51233 | |
| Domain | VWD | 3.36e-04 | 16 | 32 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.36e-04 | 16 | 32 | 2 | IPR001846 | |
| Domain | VWD | 3.36e-04 | 16 | 32 | 2 | PF00094 | |
| Domain | VWC_out | 4.78e-04 | 19 | 32 | 2 | SM00215 | |
| Domain | VWC | 1.92e-03 | 38 | 32 | 2 | SM00214 | |
| Domain | VWF_dom | 2.35e-03 | 42 | 32 | 2 | IPR001007 | |
| Domain | EGF_extracell | 4.73e-03 | 60 | 32 | 2 | IPR013111 | |
| Domain | EGF_2 | 4.73e-03 | 60 | 32 | 2 | PF07974 | |
| Domain | TPR-like_helical_dom | 7.28e-03 | 233 | 32 | 3 | IPR011990 | |
| Domain | EGF-like_CS | 9.92e-03 | 261 | 32 | 3 | IPR013032 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.23e-06 | 13 | 24 | 3 | MM14952 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 7.51e-06 | 23 | 24 | 3 | MM14953 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.38e-05 | 28 | 24 | 3 | M27254 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.52e-05 | 38 | 24 | 3 | M27255 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 7.58e-05 | 136 | 24 | 4 | M42547 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 9.07e-05 | 52 | 24 | 3 | MM14949 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 1.07e-04 | 55 | 24 | 3 | MM15137 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.19e-04 | 57 | 24 | 3 | M27251 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 1.42e-04 | 160 | 24 | 4 | MM15990 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.85e-04 | 66 | 24 | 3 | MM17074 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 2.30e-04 | 71 | 24 | 3 | M39690 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.49e-04 | 73 | 24 | 3 | MM14948 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.81e-04 | 76 | 24 | 3 | M48037 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.52e-04 | 82 | 24 | 3 | M27250 | |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 4.04e-04 | 86 | 24 | 3 | MM15140 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 4.18e-04 | 18 | 24 | 2 | MM15964 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.33e-04 | 88 | 24 | 3 | M16004 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.93e-04 | 92 | 24 | 3 | MM14951 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 5.25e-04 | 94 | 24 | 3 | MM14515 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.48e-04 | 101 | 24 | 3 | M27253 | |
| Pathway | WP_MAPK_SIGNALING | 7.30e-04 | 246 | 24 | 4 | M39597 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 9.92e-04 | 267 | 24 | 4 | M10792 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 1.25e-03 | 31 | 24 | 2 | M27252 | |
| Pathway | KEGG_SPLICEOSOME | 1.26e-03 | 127 | 24 | 3 | M2044 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.40e-03 | 505 | 24 | 5 | MM15548 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.60e-03 | 138 | 24 | 3 | MM15635 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.07e-03 | 151 | 24 | 3 | M550 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 2.12e-03 | 1128 | 24 | 7 | M1036 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.87e-03 | 47 | 24 | 2 | M39829 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23352621 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 8.54e-10 | 3 | 34 | 3 | 15129916 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 28025138 | ||
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 3.41e-09 | 4 | 34 | 3 | 22956628 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 18379898 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 3.41e-09 | 4 | 34 | 3 | 18299791 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 8.52e-09 | 5 | 34 | 3 | 16906134 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 8.52e-09 | 5 | 34 | 3 | 11584023 | |
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 17182002 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 9305631 | ||
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 1.70e-08 | 6 | 34 | 3 | 11032181 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 1.70e-08 | 6 | 34 | 3 | 25281747 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 1.70e-08 | 6 | 34 | 3 | 7988674 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 1.70e-08 | 6 | 34 | 3 | 15963462 | |
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 2.98e-08 | 7 | 34 | 3 | 10205060 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 4.76e-08 | 8 | 34 | 3 | 9122205 | |
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 21763498 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 23921388 | ||
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 7906708 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.02e-07 | 10 | 34 | 3 | 11932435 | |
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 12832005 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 1.40e-07 | 11 | 34 | 3 | 27708256 | |
| Pubmed | 1.40e-07 | 11 | 34 | 3 | 24318877 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 1.87e-07 | 12 | 34 | 3 | 19275587 | |
| Pubmed | 1.87e-07 | 12 | 34 | 3 | 12150907 | ||
| Pubmed | 1.87e-07 | 12 | 34 | 3 | 18385140 | ||
| Pubmed | 2.42e-07 | 13 | 34 | 3 | 30792309 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 2.42e-07 | 13 | 34 | 3 | 27477512 | |
| Pubmed | 3.85e-07 | 15 | 34 | 3 | 10964507 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 4.74e-07 | 16 | 34 | 3 | 21738476 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 9.28e-07 | 2 | 34 | 2 | 12411538 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 2868009 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 25618331 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 9.28e-07 | 2 | 34 | 2 | 24328534 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 3786141 | ||
| Pubmed | The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. | 9.28e-07 | 2 | 34 | 2 | 21296977 | |
| Pubmed | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. | 9.28e-07 | 2 | 34 | 2 | 16679378 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17617616 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19639652 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26448330 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29323151 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12714332 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19299581 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 9.28e-07 | 2 | 34 | 2 | 21108992 | |
| Pubmed | The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. | 9.28e-07 | 2 | 34 | 2 | 15232679 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16100242 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15498567 | ||
| Pubmed | Biological activity of truncated C-terminus human heat shock protein 72. | 9.28e-07 | 2 | 34 | 2 | 21094186 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 9.28e-07 | 2 | 34 | 2 | 26923070 | |
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 9.28e-07 | 2 | 34 | 2 | 31320473 | |
| Pubmed | Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. | 9.28e-07 | 2 | 34 | 2 | 18772114 | |
| Pubmed | Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors. | 9.28e-07 | 2 | 34 | 2 | 38703814 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16482515 | ||
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 9.28e-07 | 2 | 34 | 2 | 17482577 | |
| Pubmed | Structure and function of Hip, an attenuator of the Hsp70 chaperone cycle. | 9.28e-07 | 2 | 34 | 2 | 23812373 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19605647 | ||
| Pubmed | Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions. | 9.28e-07 | 2 | 34 | 2 | 12114509 | |
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 9.28e-07 | 2 | 34 | 2 | 11864979 | |
| Pubmed | Structure and expression of an inducible HSP70-encoding gene from Mus musculus. | 9.28e-07 | 2 | 34 | 2 | 8076831 | |
| Pubmed | The 70 kDa heat shock protein protects against experimental traumatic brain injury. | 9.28e-07 | 2 | 34 | 2 | 23816752 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16971451 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15719414 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26976620 | ||
| Pubmed | Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation. | 9.28e-07 | 2 | 34 | 2 | 21970979 | |
| Pubmed | Induction of heat shock protein 70 inhibits ischemic renal injury. | 9.28e-07 | 2 | 34 | 2 | 21270764 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15748471 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 9.28e-07 | 2 | 34 | 2 | 21187371 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20849898 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29631603 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21757701 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19005184 | ||
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 9.28e-07 | 2 | 34 | 2 | 20430459 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 9.28e-07 | 2 | 34 | 2 | 20876613 | |
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 9.28e-07 | 2 | 34 | 2 | 26197988 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20223214 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16361353 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12840151 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17234954 | ||
| Pubmed | Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. | 9.28e-07 | 2 | 34 | 2 | 22792201 | |
| Pubmed | Structure of a new crystal form of human Hsp70 ATPase domain. | 9.28e-07 | 2 | 34 | 2 | 10216320 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 9.28e-07 | 2 | 34 | 2 | 23704948 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 3931075 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9820195 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19157555 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21135124 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 14672969 | ||
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 9.28e-07 | 2 | 34 | 2 | 2858050 | |
| Pubmed | Regulation of hsp70 mRNA levels during oocyte maturation and zygotic gene activation in the mouse. | 9.28e-07 | 2 | 34 | 2 | 2010034 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 37298493 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17513788 | ||
| Pubmed | Heat-shock protein 70 genes and human longevity: a view from Denmark. | 9.28e-07 | 2 | 34 | 2 | 16804002 | |
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 9.28e-07 | 2 | 34 | 2 | 12207910 | |
| Pubmed | Genetic Modulation of HSPA1A Accelerates Kindling Progression and Exerts Pro-convulsant Effects. | 9.28e-07 | 2 | 34 | 2 | 29964156 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16735677 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28837204 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 3019832 | ||
| Interaction | CCDC117 interactions | 8.37e-06 | 26 | 31 | 3 | int:CCDC117 | |
| Interaction | PDLIM4 interactions | 9.40e-06 | 27 | 31 | 3 | int:PDLIM4 | |
| Interaction | BMX interactions | 1.07e-05 | 90 | 31 | 4 | int:BMX | |
| Interaction | METTL21A interactions | 2.27e-05 | 36 | 31 | 3 | int:METTL21A | |
| Interaction | FAM83F interactions | 2.27e-05 | 36 | 31 | 3 | int:FAM83F | |
| Interaction | PPP1R15A interactions | 3.13e-05 | 40 | 31 | 3 | int:PPP1R15A | |
| Interaction | RNF207 interactions | 4.79e-05 | 7 | 31 | 2 | int:RNF207 | |
| Interaction | TRIM38 interactions | 5.10e-05 | 47 | 31 | 3 | int:TRIM38 | |
| Interaction | TSSK6 interactions | 5.10e-05 | 47 | 31 | 3 | int:TSSK6 | |
| Interaction | HEY1 interactions | 6.07e-05 | 140 | 31 | 4 | int:HEY1 | |
| Interaction | LGALS3BP interactions | 6.98e-05 | 286 | 31 | 5 | int:LGALS3BP | |
| Interaction | CCNI2 interactions | 8.19e-05 | 9 | 31 | 2 | int:CCNI2 | |
| Interaction | HSPA1B interactions | 8.88e-05 | 301 | 31 | 5 | int:HSPA1B | |
| Interaction | CCDC142 interactions | 1.02e-04 | 10 | 31 | 2 | int:CCDC142 | |
| Interaction | DNAI1 interactions | 1.25e-04 | 11 | 31 | 2 | int:DNAI1 | |
| Interaction | ENDOG interactions | 1.75e-04 | 71 | 31 | 3 | int:ENDOG | |
| Interaction | LRRC28 interactions | 1.77e-04 | 13 | 31 | 2 | int:LRRC28 | |
| Interaction | LRRC56 interactions | 1.77e-04 | 13 | 31 | 2 | int:LRRC56 | |
| Interaction | CFAP52 interactions | 1.77e-04 | 13 | 31 | 2 | int:CFAP52 | |
| Interaction | NNMT interactions | 2.06e-04 | 14 | 31 | 2 | int:NNMT | |
| Interaction | RAPGEF6 interactions | 2.32e-04 | 78 | 31 | 3 | int:RAPGEF6 | |
| Interaction | FCGBP interactions | 2.37e-04 | 15 | 31 | 2 | int:FCGBP | |
| Interaction | CYP2W1 interactions | 2.37e-04 | 15 | 31 | 2 | int:CYP2W1 | |
| Interaction | C3orf38 interactions | 3.07e-04 | 17 | 31 | 2 | int:C3orf38 | |
| Interaction | TECPR2 interactions | 3.07e-04 | 17 | 31 | 2 | int:TECPR2 | |
| Interaction | S100A11 interactions | 3.09e-04 | 86 | 31 | 3 | int:S100A11 | |
| Interaction | CNTNAP1 interactions | 3.20e-04 | 87 | 31 | 3 | int:CNTNAP1 | |
| Interaction | ILRUN interactions | 3.45e-04 | 18 | 31 | 2 | int:ILRUN | |
| Cytoband | 3q25.1 | 2.77e-04 | 33 | 34 | 2 | 3q25.1 | |
| GeneFamily | Heat shock 70kDa proteins | 1.57e-06 | 17 | 25 | 3 | 583 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.97e-07 | 10 | 32 | 3 | MM1243 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 4.22e-06 | 26 | 32 | 3 | M1380 | |
| Coexpression | DAUER_STAT3_TARGETS_DN | 2.75e-05 | 48 | 32 | 3 | M13696 | |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 2.93e-05 | 49 | 32 | 3 | M39116 | |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP | 5.33e-05 | 170 | 32 | 4 | M38971 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 6.46e-05 | 10 | 32 | 2 | M15228 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN | 1.00e-04 | 200 | 32 | 4 | M3866 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M7372 | |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 1.71e-04 | 16 | 32 | 2 | MM559 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.90e-06 | 162 | 34 | 4 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.79e-06 | 177 | 34 | 4 | 3d1b142aa2bd18df14816abaca356596b297394e | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 9.79e-06 | 177 | 34 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.00e-05 | 178 | 34 | 4 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 1.09e-05 | 182 | 34 | 4 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 189 | 34 | 4 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 190 | 34 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 190 | 34 | 4 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-05 | 196 | 34 | 4 | d79a84aa25ba70483ae899cd5b52ba0bbffdcd7b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 197 | 34 | 4 | a97556e9fbb24272de51f54ecda6ab9ccb97a61e | |
| ToppCell | (2)_MNPs-(2)_Dendritic_Cells|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.52e-05 | 198 | 34 | 4 | 4c1f155298b7d0afddfeb2744b369a1ffd823916 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.55e-05 | 199 | 34 | 4 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-05 | 81 | 34 | 3 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-04 | 150 | 34 | 3 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.09e-04 | 152 | 34 | 3 | 530d5427d8617dcb223d807b73abee0ef89285f3 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 152 | 34 | 3 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 152 | 34 | 3 | fa03262e2853b7d35ef8cdbb652930abad90563c | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-04 | 153 | 34 | 3 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.14e-04 | 153 | 34 | 3 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.14e-04 | 153 | 34 | 3 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-04 | 153 | 34 | 3 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 155 | 34 | 3 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 157 | 34 | 3 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-04 | 159 | 34 | 3 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | 343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 160 | 34 | 3 | a2f09b5955602819c8978f4372130c8ef915cd07 | |
| ToppCell | 343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 160 | 34 | 3 | 133ecae0a894d9a0d49d58859623359096b6f030 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 161 | 34 | 3 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 162 | 34 | 3 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 163 | 34 | 3 | 93bc67a13267c858cabc81eafe1c9b966d872a9e | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 165 | 34 | 3 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 165 | 34 | 3 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.67e-04 | 165 | 34 | 3 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 165 | 34 | 3 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 167 | 34 | 3 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 168 | 34 | 3 | 696b31bedbc7d40817a733e8c6ec2633404be619 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.86e-04 | 169 | 34 | 3 | d5624e5b3687bd3f18f3a2b47a94d11eb1fbdb75 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 169 | 34 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 170 | 34 | 3 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 171 | 34 | 3 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 171 | 34 | 3 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 175 | 34 | 3 | baaffc9af61f12168d6f7b96eb0b6e98a44a3909 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.22e-04 | 176 | 34 | 3 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-04 | 177 | 34 | 3 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 3.27e-04 | 177 | 34 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 177 | 34 | 3 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-04 | 178 | 34 | 3 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-04 | 179 | 34 | 3 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-04 | 179 | 34 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-04 | 179 | 34 | 3 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-04 | 179 | 34 | 3 | 9af894dfbe44e9706f5d178769ceda3b4e2d89c0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.44e-04 | 180 | 34 | 3 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.44e-04 | 180 | 34 | 3 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.44e-04 | 180 | 34 | 3 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-04 | 180 | 34 | 3 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class (2021.01.30) | 3.44e-04 | 180 | 34 | 3 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 180 | 34 | 3 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.44e-04 | 180 | 34 | 3 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 181 | 34 | 3 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-04 | 181 | 34 | 3 | e8c715fa3a0fed43ad4788b2d06cf45ab2c9e202 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 3.55e-04 | 182 | 34 | 3 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 3.55e-04 | 182 | 34 | 3 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.55e-04 | 182 | 34 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-04 | 183 | 34 | 3 | 514b72a1ae55656934839800513385e19bc240e2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-04 | 183 | 34 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-04 | 184 | 34 | 3 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-04 | 184 | 34 | 3 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-04 | 184 | 34 | 3 | a068ae741889d59937690c11e0bf405481402c25 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 3.73e-04 | 185 | 34 | 3 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 3.73e-04 | 185 | 34 | 3 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-04 | 185 | 34 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-04 | 185 | 34 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | ea3ff0bd3f312bd2e93227ecf6ed577366aab3e0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-04 | 185 | 34 | 3 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 3.73e-04 | 185 | 34 | 3 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 185 | 34 | 3 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-04 | 187 | 34 | 3 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class (2021.01.30) | 3.85e-04 | 187 | 34 | 3 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-04 | 187 | 34 | 3 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.85e-04 | 187 | 34 | 3 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.85e-04 | 187 | 34 | 3 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-04 | 187 | 34 | 3 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 188 | 34 | 3 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-04 | 188 | 34 | 3 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 3.91e-04 | 188 | 34 | 3 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 188 | 34 | 3 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 188 | 34 | 3 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 3.97e-04 | 189 | 34 | 3 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.97e-04 | 189 | 34 | 3 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-04 | 189 | 34 | 3 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-04 | 189 | 34 | 3 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-04 | 189 | 34 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-04 | 189 | 34 | 3 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | ILEUM-non-inflamed|ILEUM / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.09e-04 | 191 | 34 | 3 | c4a78ef7b87ffadbb1b9b69cbfa7c164ca456f9a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.71e-05 | 50 | 19 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.71e-05 | 50 | 19 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Drug | Azetidinecarboxylic Acid | 1.15e-05 | 4 | 32 | 2 | ctd:D001383 | |
| Drug | 2-phenylacetylenesulfonamide | 1.91e-05 | 5 | 32 | 2 | ctd:C545747 | |
| Drug | polaprezinc | 2.86e-05 | 6 | 32 | 2 | ctd:C061957 | |
| Drug | geranylgeranylacetone | 2.86e-05 | 6 | 32 | 2 | ctd:C031049 | |
| Drug | formetanate | 2.86e-05 | 6 | 32 | 2 | ctd:C100163 | |
| Drug | benz(a)anthracene | 3.94e-05 | 1251 | 32 | 9 | ctd:C030935 | |
| Drug | LL Z1640-2 | 4.00e-05 | 7 | 32 | 2 | ctd:C118715 | |
| Drug | pirimicarb | 4.00e-05 | 7 | 32 | 2 | ctd:C011994 | |
| Drug | triphenyl(phenylethynyl)phosphonium | 5.33e-05 | 8 | 32 | 2 | ctd:C000608764 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.05e-08 | 5 | 31 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Major depression, single episode | 3.83e-05 | 9 | 31 | 2 | C0024517 | |
| Disease | Reperfusion Injury | 1.12e-04 | 89 | 31 | 3 | C0035126 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.91e-04 | 24 | 31 | 2 | C0887833 | |
| Disease | complement C4b measurement | 3.16e-04 | 25 | 31 | 2 | EFO_0008092 | |
| Disease | Arsenic Induced Polyneuropathy | 1.94e-03 | 62 | 31 | 2 | C0751852 | |
| Disease | Arsenic Encephalopathy | 1.94e-03 | 62 | 31 | 2 | C0751851 | |
| Disease | Arsenic Poisoning | 1.94e-03 | 62 | 31 | 2 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 1.94e-03 | 62 | 31 | 2 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 1.94e-03 | 62 | 31 | 2 | C0274862 | |
| Disease | serum dimethylarginine measurement | 2.00e-03 | 63 | 31 | 2 | EFO_0005418 | |
| Disease | Dermatologic disorders | 2.83e-03 | 75 | 31 | 2 | C0037274 | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.90e-03 | 76 | 31 | 2 | DOID:11054 (is_implicated_in) | |
| Disease | schizophrenia (is_implicated_in) | 3.05e-03 | 78 | 31 | 2 | DOID:5419 (is_implicated_in) | |
| Disease | psoriatic arthritis | 3.78e-03 | 87 | 31 | 2 | EFO_0003778 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 5.55e-03 | 106 | 31 | 2 | EFO_0803333 | |
| Disease | Drug Use Disorders | 6.50e-03 | 115 | 31 | 2 | C0013222 | |
| Disease | Drug Dependence | 6.50e-03 | 115 | 31 | 2 | C1510472 | |
| Disease | Drug habituation | 6.50e-03 | 115 | 31 | 2 | C0013170 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCESSIVIGEKNGGE | 276 | Q9P0M2 | |
| SEHMQVEEKCGGIVG | 171 | O60443 | |
| EHGGKTVEVKGGEHC | 121 | Q9P0K1 | |
| GQVCTGVHVGAKEQE | 141 | Q96MU5 | |
| EQHCSVLVKDGVGVG | 166 | O95376 | |
| VVHDEGAVCSCTGGK | 766 | Q9HC84 | |
| GELVKGCVIFQGTDH | 216 | P45984 | |
| TAQVFEGLCGVVKHV | 901 | Q86YW9 | |
| FEIQVTGGCELHSGK | 111 | P06126 | |
| SCVGVFQHGKVEIIA | 16 | P0DMV9 | |
| GGHIASVVEGQKGII | 96 | Q86VH2 | |
| NGCEEGKSQETLHGV | 316 | A8MYZ0 | |
| EGQSGVTIKHVACGD | 386 | Q86SG6 | |
| ADHTQAIVLGCVGGI | 721 | P26010 | |
| VAVIVSNDHAGKLCG | 5356 | Q9Y6R7 | |
| HIEKIIGSGDSGEVC | 636 | P29322 | |
| SCVGVFQHGKVEIIA | 16 | P0DMV8 | |
| KEHQVVVVAGDTGCG | 176 | Q14147 | |
| GVCSKGVLVFEVHNG | 796 | Q12923 | |
| SCVGVFQHGKVEIIA | 16 | P11142 | |
| VGSGGKHVTATVACQ | 351 | Q8N3T6 | |
| GCIVAHGQQSVIVDG | 511 | Q96MK3 | |
| KPGDVAVHGEAVVCV | 1161 | O14802 | |
| VETAKFGGHGICDNI | 766 | Q9UBZ9 | |
| HGVNDKVTVIGAGVT | 501 | Q9H0I9 | |
| GEHMGVCSEDGKVQV | 96 | P49754 | |
| HRVGTVAEAVACIQG | 301 | Q7RTY5 | |
| FVDEHTVCGVAKGGK | 161 | Q9NNW7 | |
| AIVGEIGHGCNEGEK | 76 | Q96JF6 | |
| SNAVVHVGGVLCVEI | 596 | P48553 | |
| GDNTGCQVVSGVFKH | 406 | Q6ZMP0 | |
| QKDGDGCTVLHVVAA | 236 | O15050 | |
| SVGECEVHKGGYNEV | 131 | A0A1W2PQL4 | |
| VHAEGKSCKGQEVGE | 341 | Q96N77 |